Symbotic Inc. is a technology company that specializes in automating supply chain operations and warehouse management using advanced robotics and artificial intelligence. The company develops innovative systems designed to enhance the efficiency and accuracy of inventory management, order fulfillment, and logistics processes for retailers and wholesalers. By integrating cutting-edge automation technologies, Symbotic aims to streamline warehousing operations, reduce labor costs, and improve overall operational performance in the supply chain sector. Their solutions are tailored to meet the demands of a rapidly evolving retail landscape, leveraging data-driven insights to optimize inventory handling and delivery.
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 3, 2025 to file lead plaintiff applications in a securities class action lawsuit against Symbotic Inc. (the “Company”) (NasdaqGM: SYM), if they purchased the Company’s securities between February 8, 2024 and November 26, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Massachusetts.
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ: SYM) securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”). Symbotic investors have until February 3, 2025 to file a lead plaintiff motion.
SAN FRANCISCO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Girard Sharp, LLP, a national investment, securities, and consumer class action firm, is investigating securities claims on behalf of Symbotic Inc. (NASDAQ: SYM) investors who sustained losses.
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Symbotic Inc. (NASDAQ: SYM) publicly traded securities between February 8, 2024 and November 26, 2024, inclusive (the “Class Period”), have until February 3, 2025 to seek appointment as lead plaintiff of the Symbotic class action lawsuit. Captioned Decker v. Symbotic Inc., No. 24-cv-12976 (D. Mass.), the Symbotic class action lawsuit charges Symbotic and certain of Symbotic’s top executives with violations of the Securities Exchange Act of 1934.
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ: SYM) securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”). Symbotic investors have until February 3, 2025 to file a lead plaintiff motion.
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ: SYM) in the United States District Court for the District of Massachusetts on behalf of all persons and entities who purchased or otherwise acquired Symbotic securities between February 8, 2024, and November 26, 2024, both dates inclusive (the “Class Period”). Investors have until February 3, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ: SYM) investors concerning the Company’s possible violations of the federal securities laws.
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Symbotic Inc. (“Symbotic” or “the Company”) (NASDAQ: SYM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ: SYM) and reminds investors of the February 3, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Symbotic Inc. (NASDAQ: SYM) between February 8, 2024 and November 26, 2024, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Symbotic investors under the federal securities laws.
The law firm of Kirby McInerney LLP is investigating potential claims against Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ:SYM). The investigation concerns whether Symbotic and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
PALM BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Innovations in robotics technology, including artificial intelligence, machine learning, and sensor technology, are enhancing the capabilities of medical robots. These advancements enable more precise surgical procedures, improved rehabilitation processes, and efficient hospital logistics, thus attracting more healthcare facilities to adopt robotic solutions. The market is characterized by a moderate level of merger and acquisition (M&A) activity by the leading players. This is due to several factors, including the desire to expand the business to cater to the growing demand for medical service robots. A report from Grand View Research said that the global medical service robots market size was estimated at USD 20.59 billion in 2024 and is projected to grow at a CAGR of 16.5% from 2025 to 2030. It said: “The growth can be attributed to the introduction of technologically advanced robotic equipment in the healthcare sector and the rise in per capita healthcare spending. Continuous advancements in technology, such as robotic catheter control systems (CCS), data recorders, data analytics, remote navigation, motion sensors, 3D-Imaging, and HD surgical microscopic cameras, are projected to drive industry growth. Furthermore, the introduction of swarm robotics is opening new opportunities for industry. It is a new approach to coordinating multi-robotic systems through swarm intelligence.” Active Tech Companies in the markets today include Jeffs' Brands Ltd (NASDAQ: JFBR), Serve Robotics Inc. (NASDAQ: SERV), Symbotic Inc. (NASDAQ: SYM), Microbot Medical Inc. (NASDAQ: MBOT), Medtronic plc (NYSE: MDT).
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., is investigating claims on behalf of Fund Managers and Investors of Symbotic Inc. (NasdaqGM: SYM) with losses in excess of $5 million. Such investors are advised to contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgm-sym/ to learn more.
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Symbotic Inc. (NASDAQ: SYM) resulting from allegations that Symbotic may have issued materially misleading business information to the investing public.
Law Offices of Howard G. Smith announces an investigation on behalf of Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ: SYM) investors concerning the Company’s possible violations of federal securities laws.
